Please select the option that best describes you:
Topics:
Genitourinary Cancers • Medical Oncology
How do you choose which LHRH agonist or antagonist to prescribe for ADT in patients with prostate cancer?
What clinical considerations factor into your decision to choose leuprolide vs goserelin vs triptorelin vs degarelix, etc?
Answer from: Medical Oncologist at Academic Institution
The choice of LHRH agonist or antagonist depends on patient factors. Most patients receive some form of leuprolide or goserelin since these allow longer intervals between injections (as compared to degarelix). Goserelin is used more for those on anticoagulation or with bleeding disorders since...
Sign in or Register to read more